Pricing Log in Create free account

Enliven Therapeutics, Inc. (ELVN) vs IDEAYA Biosciences, Inc. (IDYA)

Enliven Therapeutics, Inc. and IDEAYA Biosciences, Inc. are both Biotechnology companies. Enliven Therapeutics, Inc. is the larger, with a market value of $3.3B against $3.0B — 1.1× the size. Enliven Therapeutics, Inc. has the higher net margin (0.00% vs −1,149.6%) and the higher return on invested capital (0.00% vs −114.2%). Across the 13 metrics below, Enliven Therapeutics, Inc. leads on 10 and IDEAYA Biosciences, Inc. on 3.

Valuation

Metric ELVN IDYA Biotechnology median
P/E n/m n/m 10.26
P/S n/m 86.70 9.18
P/B 3.34 2.90 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 63.75 8.98
Earnings yield (3.69%) (14.60%) (34.89%)
Free cash flow yield (2.24%) (11.04%) (24.52%)

Profitability

Metric ELVN IDYA Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (1,267.38%) 0.00%
Net margin 0.00% (1,149.62%) 0.00%
Free cash flow margin 0.00% (957.43%) 0.00%
Return on equity (15.31%) (38.46%) (50.12%)
Return on assets (14.98%) (34.98%) (45.60%)
Return on invested capital 0.00% (114.15%) 0.00%

Growth

Metric ELVN IDYA Biotechnology median
Revenue growth (TTM) — (83.64%) 6.26%
EPS growth (last fiscal year) 3.17% 61.90% 29.88%
Revenue growth, 5-year CAGR — 62.11% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELVN IDYA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 64.07 9.04 4.89
Net debt to EBITDA 3.87 3.88 1.01

Dividend

Metric ELVN IDYA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ELVN IDYA Biotechnology median
Market cap 3.28b 2.96b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack